Advertisement
Advertisement
U.S. markets open in 6 hours 15 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Milestone Pharmaceuticals Inc. (MIST)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.20-0.10 (-1.59%)
At close: 04:00PM EDT
6.20 0.00 (0.00%)
After hours: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close6.30
Open6.27
Bid0.00 x 1400
Ask0.00 x 800
Day's Range5.93 - 6.50
52 Week Range3.98 - 8.24
Volume27,089
Avg. Volume85,404
Market Cap185.525M
Beta (5Y Monthly)3.15
PE Ratio (TTM)N/A
EPS (TTM)-1.05
Earnings DateAug 09, 2022 - Aug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for MIST

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Milestone Pharmaceuticals Inc.
    Daily – Vickers Top Insider Picks for 06/13/2022The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Rating
    Fair Value
    Economic Moat
    15 days agoArgus Research
View more
  • PR Newswire

    Milestone Pharmaceuticals to Present at the Jefferies Healthcare Conference

    Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 1:30pm ET in New York, NY.

  • PR Newswire

    Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Milestone's Compensation Committee granted three new employees incentive stock options to purchase an aggregate of 92,000 common shares, at a per share exercise price of $5.48, the closing price of Milestone's common stock on May 16, 2022. The awards were made pursuant to the NASDAQ inducement grant exception as a

  • Simply Wall St.

    We Think Milestone Pharmaceuticals (NASDAQ:MIST) Can Afford To Drive Business Growth

    Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Advertisement
Advertisement